[January 10, 2013]

Research and Markets: Opthalmics Partnering Terms & Agreements: Key Analysis of how and why Companies Enter Opthalmics Partnering Deals

Research and Markets (http://www.researchandmarkets.com/research/d3hwjp/opthalmics) has announced the addition of the "Opthalmics Partnering Terms & Agreements" report to their offering.

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors opthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Key benefits

Opthalmics Partnering Terms and Agreements provides the reader with the following key benefits:

- In-depth understanding of opthalmics deal trends since 2007

- Access opthalmicsdeal headline, upfront, milestone and royalty data

- Research hundreds of actual contracts between opthalmics partner companies

- Comprehensive access to over 1500 links to actual opthalmics deals entered into by the world's biopharma companies

- Indepth review of dental deals entered into by the leading fifty bigpharma companies

- Benchmark the key deal terms companies have agreed in previous deals

- Identify key terms under which companies partner opthalmics opportunities

- Uncover companies actively partnering opthalmics opportunities

Opthalmics Partnering Terms and Agreements includes:

- Trends in opthalmics dealmaking in the biopharma industry since 2007

- Analysis of opthalmics deal structure

- Access to headline, upfront, milestone and royalty data

- Access to hundreds of opthalmics deal contract documents

- Comprehensive access to over 350 opthalmics deal records

- The leading opthalmics deals by value since 2007

- Most active opthalmics dealmakers since 2007

In Opthalmics Partnering Terms and Agreements, available deals and contracts are listed by:

- Headline value o Upfront payment value

- Royalty rate value o Stage of development at signing

- Deal component type

- Technology type

- Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in opthalmics dealmaking

Chapter 3 - Leading opthalmics deals

Chapter 4 - Bigpharma opthalmics deals

Chapter 5 - Opthalmics partnering contracts directory

Chapter 6 - Opthalmics dealmaking by therapeutic target

For more information visit http://www.researchandmarkets.com/research/d3hwjp/opthalmics

[ Back To Technology News's Homepage ]